NCT05070988

Brief Summary

The main objective of the study is to assess the oral health-related quality of life of patients with rare diseases and followed in the rare disease centers of expertise at Necker Hospital in Paris by semi-structured interviews.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
28

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Oct 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 27, 2021

Completed
10 days until next milestone

First Posted

Study publicly available on registry

October 7, 2021

Completed
13 days until next milestone

Study Start

First participant enrolled

October 20, 2021

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 29, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 29, 2021

Completed
Last Updated

September 12, 2025

Status Verified

September 1, 2025

Enrollment Period

1 month

First QC Date

September 27, 2021

Last Update Submit

September 5, 2025

Conditions

Keywords

Rare diseasesOral health-related quality of lifeQualitative method

Outcome Measures

Primary Outcomes (1)

  • Oral health-related quality of life assessment

    Qualitative method from a semi-structured interview.

    Day 0

Secondary Outcomes (2)

  • Description of oral health care pathways

    Day 0

  • Inequalities in access to oral health care

    Day 0

Study Arms (1)

Rare diseases

Children and adult patients with rare diseases and followed at the Necker Enfant Malades Hospital, Paris

Other: Semi-structured interview

Interventions

Semi-structured interview with the investigating doctor of the study lasting 30 minutes to an hour

Rare diseases

Eligibility Criteria

Age6 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population is that of the centers of expertise for rare diseases at the Necker Hospital in Paris, France.

You may qualify if:

  • Minor and adult patients with rare diseases aged of at least 6 years old and followed at the Necker Enfant Malades Hospital, Paris
  • Patients with the 3 most frequent rare diseases of each rare disease Necker reference center participating in the study (10 centers : Chronic And Malformative Disorders Of The Esophagus / Inflammatory diseases of the bile ducts and autoimmune hepatitis / Constitutional Bone Diseases / Inherited Metabolic Diseases / Biliary Atresia And Genetic Cholestases / Vascular Diseases Of The Liver / Developmental Anomalies and Malformative Syndromes of Ile-De-France / Rare Causes Intellectual Disabilities / Complex congenital heart defects / Childhood cerebrovascular pathologies)
  • Patients who consulted between 1.1.2017 and 1.1.2020 the relevant rare disease reference center at Necker hospital
  • Patients seen at least once in the medical genetics department of Necker Hospital
  • Information and non-opposition of adult patients / holders of parental authority of minor patients and minor patients to participate in the study

You may not qualify if:

  • Patients who do not speak French

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hôpital Necker-Enfants Malades

Paris, 75015, France

Location

Related Publications (1)

  • Friedlander L, Berdal A, Cormier-Daire V, Lyonnet S, Garcelon N. Determinants of dental care use in patients with rare diseases: a qualitative exploration. BMC Oral Health. 2023 Jun 22;23(1):413. doi: 10.1186/s12903-023-03048-1.

    PMID: 37349716BACKGROUND

MeSH Terms

Conditions

Rare Diseases

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Lisa Friedlander, DDS, PHD, associate professor

    Assistance Publique - Hôpitaux de Paris

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 27, 2021

First Posted

October 7, 2021

Study Start

October 20, 2021

Primary Completion

November 29, 2021

Study Completion

November 29, 2021

Last Updated

September 12, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

Locations